Kelly Shi
Stock Analyst at Jefferies
(3.19)
# 1,178
Out of 5,093 analysts
32
Total ratings
45.16%
Success rate
17.19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTCT PTC Therapeutics | Maintains: Buy | $63 → $77 | $74.22 | +3.75% | 4 | Oct 28, 2025 | |
| INSM Insmed | Maintains: Buy | $129 → $148 | $194.22 | -23.80% | 2 | Aug 13, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $23 → $28 | $38.70 | -27.65% | 1 | Jul 7, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $31 → $44 | $17.10 | +157.31% | 1 | Apr 25, 2025 | |
| VSTM Verastem | Initiates: Buy | $15 | $10.14 | +47.93% | 1 | Apr 10, 2025 | |
| TIL Instil Bio | Upgrades: Buy | $11 → $52 | $11.00 | +372.73% | 2 | Jan 7, 2025 | |
| FHTX Foghorn Therapeutics | Maintains: Buy | $18 → $14 | $4.38 | +219.64% | 2 | Dec 16, 2024 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $13 → $19 | $28.77 | -33.95% | 2 | Sep 11, 2024 | |
| ASND Ascendis Pharma | Maintains: Buy | $174 → $196 | $198.89 | -1.45% | 2 | Aug 13, 2024 | |
| ARTV Artiva Biotherapeutics | Initiates: Buy | $21 | $3.09 | +580.71% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $19.57 | +89.06% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $6 | $2.22 | +170.88% | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $95.46 | -15.15% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $25.11 | +39.39% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $2.51 | +1,334.26% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $14.55 | +10.00% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $87.34 | -54.20% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $17.21 | +16.21% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $2.23 | +259.55% | 1 | Aug 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $0.53 | +4,978.05% | 1 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $13.71 | +279.29% | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $2.38 | +1,034.45% | 1 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $1.91 | +1,627.75% | 1 | Mar 8, 2021 |
PTC Therapeutics
Oct 28, 2025
Maintains: Buy
Price Target: $63 → $77
Current: $74.22
Upside: +3.75%
Insmed
Aug 13, 2025
Maintains: Buy
Price Target: $129 → $148
Current: $194.22
Upside: -23.80%
Cogent Biosciences
Jul 7, 2025
Maintains: Buy
Price Target: $23 → $28
Current: $38.70
Upside: -27.65%
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31 → $44
Current: $17.10
Upside: +157.31%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $10.14
Upside: +47.93%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11 → $52
Current: $11.00
Upside: +372.73%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $4.38
Upside: +219.64%
Centessa Pharmaceuticals
Sep 11, 2024
Maintains: Buy
Price Target: $13 → $19
Current: $28.77
Upside: -33.95%
Ascendis Pharma
Aug 13, 2024
Maintains: Buy
Price Target: $174 → $196
Current: $198.89
Upside: -1.45%
Artiva Biotherapeutics
Aug 13, 2024
Initiates: Buy
Price Target: $21
Current: $3.09
Upside: +580.71%
Jun 28, 2024
Initiates: Buy
Price Target: $37
Current: $19.57
Upside: +89.06%
Jun 10, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $2.22
Upside: +170.88%
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $95.46
Upside: -15.15%
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $25.11
Upside: +39.39%
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $2.51
Upside: +1,334.26%
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $14.55
Upside: +10.00%
Aug 15, 2022
Initiates: Buy
Price Target: $40
Current: $87.34
Upside: -54.20%
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $17.21
Upside: +16.21%
Aug 3, 2022
Initiates: Buy
Price Target: $8
Current: $2.23
Upside: +259.55%
Mar 4, 2022
Initiates: Buy
Price Target: $27
Current: $0.53
Upside: +4,978.05%
Aug 3, 2021
Initiates: Buy
Price Target: $52
Current: $13.71
Upside: +279.29%
Apr 13, 2021
Initiates: Buy
Price Target: $27
Current: $2.38
Upside: +1,034.45%
Mar 8, 2021
Initiates: Buy
Price Target: $33
Current: $1.91
Upside: +1,627.75%